Skip to main content

Table 3 Study the risk of development of DM in different genotypes and alleles

From: Study of transcription factor 7-like 2 (TCF7L2) gene polymorphism in cirrhotic patients with diabetes

TCF7L2

DM vs. control

DM vs. cirrhotic

Cirrhotic diabetic vs. control

Cirrhotic diabetic vs. DM

Cirrhotic diabetic vs. cirrhotic

OR (95% C.I)

p value

OR (95% CI)

p value

OR (95% CI)

p value

OR (95% CI)

p value

OR (95% CI)

p value

Genotypes

CC®

Ref

Ref

 

Ref

Ref

Ref

CT

3.385 (0.870–13.166)

0.072

2.857 (0.731–11.171)

0.124

5.07 (1.176–21.914)

0.023*

1.50 (0.29–7.74)

0.697 (FE)

4.29 (0.99–18.59)

0.043*

TT

13.750(1.207 − 156.66)

0.046*(FE)

12.500(1.089–143.439)

FEp = 0.049*

14.67(1.16–185.24)

0.038*(FE)

1.067 (0.15–7.82)

1.000 (FE)

13.33 (1.05–169.57)

0.047*(FE)

Dominant model

CC®

Ref

Ref

 

Ref

Ref

Ref

CT + TT

4.125 (1.092–15.586)

0.031*

3.500 (0.921–13.307)

0.056

5.76 (1.36–24.36)

0.012*

1.40 (0.28–7.00)

1.000 (FE)

4.89 (1.15–20.79)

0.024*

Recessive model

CC + CT

Ref

Ref

-

Ref

Ref

Ref

TT

6.00 (0.647–55.664)

0.189(FE)

6.000 (0.647–55.664)

FEp = 0.189

4.57 (0.47–44.17)

0.349 (FE)

0.76 (0.18–3.25)

1.000 (FE)

4.57 (0.47–44.17)

0.349(FE)

Alleles

Ref

Ref

-

Ref

Ref

Ref

T

2.528 (1.112–5.744)

0.025*

2.302 (1.021–5.190)

0.043*

2.53 (1.11–5.74)

2.53 (1.11–5.74)

1.00 (0.46–2.19)

1.000 (FE)

2.30 (1.02–5.19)

0.043*

  1. FE Fisher’s exact, OR odds ratio, CI confidence interval, LL lower limit, UL upper limit, p p value for comparing between the studied groups
  2. *Statistically significant at p ≤ 0.05
  3. ®Reference group